• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚焦教育可提高肝硬化患者的肝细胞癌筛查率,与功能性健康素养无关。

Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.

机构信息

Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA.

Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Dig Dis Sci. 2021 Aug;66(8):2603-2609. doi: 10.1007/s10620-020-06583-x. Epub 2020 Sep 5.

DOI:10.1007/s10620-020-06583-x
PMID:32889600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7933309/
Abstract

BACKGROUND

Health education interventions are successful in modifying lifestyle. Functional health literacy (FHL) can determine patient adherence to clinic visits and procedures and may adversely impact the success of these interventions.

AIMS

We sought to evaluate the hypothesis that a health education intervention would improve compliance with hepatocellular cancer (HCC) screening and that poor FHL would reduce such compliance.

METHODS

We assessed FHL using a short version test of functional health literacy in adults (STOFHLA). Cirrhotic patients free of HCC were prospectively enrolled from clinics and provided an educational intervention consisting of focused physician-led discussion regarding cirrhosis and HCC, along with written material on these topics for the subject to review at home. Patients were subsequently followed for 6 months (prospective time period), and the same cohort's clinic/HCC screening behavior between 6 and 12 months prior to the educational intervention (retrospective time period) was compared.

RESULTS

In total, 104 cirrhotic patients (age 60.01 ± 8.58 years, 80% men, MELD 12.70 ± 5.76) were included. Of these, 89 (85.57%) of patients had educational level 12th grade and higher. There were 76% (n = 79) with adequate, while 24% (n = 25) had inadequate/marginal FHL on S-TOHFLA. The number of HCC-related imaging increased from 59 (56.7%) to 86 (82.6%, p < 0.0001) post-education in the prospective compared to prior time period which was similar regardless of FHL.

CONCLUSIONS

While the educational intervention was successful in improving compliance with HCC screenings, FHL status did not impact the power of this intervention. Hence, the combination of specific verbal information, along with targeted written material, improved compliance with clinic visits and liver imaging for HCC.

摘要

背景

健康教育干预措施在改变生活方式方面取得了成功。功能性健康素养(FHL)可以确定患者对就诊和治疗的依从性,并且可能对这些干预措施的成功产生不利影响。

目的

我们旨在验证假设,即健康教育干预措施可提高肝细胞癌(HCC)筛查的依从性,而较差的 FHL 则会降低这种依从性。

方法

我们使用成人功能性健康素养简短测试(STOFHLA)评估 FHL。从诊所前瞻性招募无 HCC 的肝硬化患者,并提供一个教育干预,包括由医生主导的关于肝硬化和 HCC 的讨论,以及关于这些主题的书面材料,供患者在家中复习。随后对患者进行了 6 个月的随访(前瞻性时间段),并比较了教育干预前 6 至 12 个月同一队列的就诊/HCC 筛查行为(回顾性时间段)。

结果

共有 104 名肝硬化患者(年龄 60.01±8.58 岁,80%为男性,MELD 12.70±5.76)被纳入研究。其中 89 名(85.57%)患者的教育水平达到 12 年级及以上。在 S-TOHFLA 上,76%(n=79)患者具有足够的 FHL,而 24%(n=25)患者具有不足/边缘 FHL。与回顾性时间段相比,前瞻性时间段接受教育后 HCC 相关影像学检查的数量从 59 次(56.7%)增加到 86 次(82.6%,p<0.0001),而无论 FHL 如何,这一比例都相似。

结论

尽管教育干预成功地提高了 HCC 筛查的依从性,但 FHL 状况并未影响该干预措施的效果。因此,特定的口头信息与针对性的书面材料相结合,提高了就诊和 HCC 肝脏影像学检查的依从性。

相似文献

1
Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.聚焦教育可提高肝硬化患者的肝细胞癌筛查率,与功能性健康素养无关。
Dig Dis Sci. 2021 Aug;66(8):2603-2609. doi: 10.1007/s10620-020-06583-x. Epub 2020 Sep 5.
2
Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.在社区环境中,对肝硬化或慢性乙型肝炎患者进行肝细胞癌筛查的依从性。
Dig Dis Sci. 2009 Dec;54(12):2712-21. doi: 10.1007/s10620-009-1015-x. Epub 2009 Oct 30.
3
Factors affecting screening for hepatocellular carcinoma.影响肝细胞癌筛查的因素。
Ann Hepatol. 2014 Mar-Apr;13(2):204-10.
4
Hepatocellular carcinoma among cirrhotics--utility of screening and surveillance programs--review article.肝硬化患者中的肝细胞癌——筛查和监测计划的效用——综述文章
J Med Life. 2014 Oct-Dec;7(4):477-80.
5
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach.对已知丙型肝炎病毒(HCV)相关肝硬化且代偿良好的患者进行肝细胞癌筛查可改善生存:一种建模方法。
Hepatology. 2014 Apr;59(4):1471-81. doi: 10.1002/hep.26944. Epub 2014 Feb 25.
6
Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.在非病毒性肝硬化患者中,利用血清甲胎蛋白检测和腹部超声进行肝细胞癌筛查比单纯使用超声更有效。
J Gastrointest Cancer. 2018 Dec;49(4):476-480. doi: 10.1007/s12029-017-0006-y.
7
Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.美国肝硬化患者的肝癌筛查与早期肿瘤检测和生存改善相关。
Am J Med. 2017 Sep;130(9):1099-1106.e1. doi: 10.1016/j.amjmed.2017.01.021. Epub 2017 Feb 14.
8
Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.超声造影每半年 1 次与非增强磁共振成像每年 1 次作为肝硬化患者肝癌监测工具的比较(MAGNUS-HCC):研究方案。
BMC Cancer. 2017 Dec 21;17(1):877. doi: 10.1186/s12885-017-3819-y.
9
Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.非酒精性脂肪性肝炎肝硬化患者的肝细胞癌筛查不足。
J Clin Gastroenterol. 2019 Feb;53(2):142-146. doi: 10.1097/MCG.0000000000001075.
10
Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B.慢性乙型肝炎患者肝细胞癌监测的依从性差和持续性率低。
Medicine (Baltimore). 2016 Aug;95(35):e4744. doi: 10.1097/MD.0000000000004744.

引用本文的文献

1
Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review.英国肝细胞癌监测、诊断、治疗及生存方面的健康不平等:一项范围综述
BJC Rep. 2025 Mar 3;3(1):13. doi: 10.1038/s44276-025-00126-5.
2
Screening high-risk Veterans for cirrhosis: taking a stepwise population health approach.对高危退伍军人进行肝硬化筛查:采取循序渐进的人群健康方法。
BMC Health Serv Res. 2025 Jan 29;25(1):168. doi: 10.1186/s12913-025-12216-8.
3
mhealth-based interventions to improving liver cancer screening among high-risk populations: a study protocol for a randomized controlled trial.基于移动医疗的干预措施提高高危人群肝癌筛查率:一项随机对照试验的研究方案。
BMC Public Health. 2024 Sep 13;24(1):2501. doi: 10.1186/s12889-024-20025-7.
4
Genetic screening of liver cancer: State of the art.肝癌的基因筛查:当前技术水平
World J Hepatol. 2024 May 27;16(5):716-730. doi: 10.4254/wjh.v16.i5.716.
5
Interventions to Improve Surveillance for Hepatocellular Carcinoma in High-Risk Patients: A Scoping Review.干预措施以提高高危患者肝癌监测:范围综述。
J Gastrointest Cancer. 2024 Mar;55(1):1-14. doi: 10.1007/s12029-023-00944-1. Epub 2023 Jun 16.
6
Development of a nurse-led decision counseling program for improving hepatocellular carcinoma screening: A typology-guided feasibility study.开发护士主导的决策咨询项目以改善肝细胞癌筛查:一项类型学指导的可行性研究。
Asia Pac J Oncol Nurs. 2023 Mar 9;10(6):100215. doi: 10.1016/j.apjon.2023.100215. eCollection 2023 Jun.
7
Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.美国高危人群肝癌监测的患者、提供者和系统层面障碍:范围综述。
J Gastrointest Cancer. 2023 Jun;54(2):332-356. doi: 10.1007/s12029-022-00851-x. Epub 2022 Jul 26.

本文引用的文献

1
Impact of a cancer education seminar on knowledge and screening intent among Chinese Americans: Results from a randomized, controlled, community-based trial.癌症教育研讨会对美籍华人知识和筛查意愿的影响:一项基于社区的随机对照试验的结果。
Cancer. 2018 Apr 1;124 Suppl 7:1622-1630. doi: 10.1002/cncr.31111.
2
Impact of educational interventions on primary prevention of cardiovascular disease: A systematic review with a focus on physical activity.教育干预对心血管疾病一级预防的影响:一项聚焦于身体活动的系统评价
Eur J Gen Pract. 2017 Dec;23(1):59-68. doi: 10.1080/13814788.2017.1284791.
3
AASLD guidelines for the treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌治疗指南。
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.
4
Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.邮件外展项目增加了对肝硬化患者进行肝细胞癌超声筛查的比例。
Gastroenterology. 2017 Feb;152(3):608-615.e4. doi: 10.1053/j.gastro.2016.10.042. Epub 2016 Nov 5.
5
Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.患者报告的障碍与肝硬化患者较低的肝细胞癌监测率相关。
Hepatology. 2017 Mar;65(3):875-884. doi: 10.1002/hep.28770. Epub 2016 Oct 1.
6
Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.在全国肝硬化患者样本中识别肝细胞癌监测的障碍。
Hepatology. 2017 Mar;65(3):864-874. doi: 10.1002/hep.28765. Epub 2016 Oct 5.
7
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.美国肝细胞癌发病率至2030年的预测前景
J Clin Oncol. 2016 May 20;34(15):1787-94. doi: 10.1200/JCO.2015.64.7412. Epub 2016 Apr 4.
8
The Effectiveness of a Physician-Only and Physician-Patient Intervention on Colorectal Cancer Screening Discussions Between Providers and African American and Latino Patients.仅医生参与及医生-患者共同参与的干预措施对医疗服务提供者与非裔美国人和拉丁裔患者之间结直肠癌筛查讨论的有效性。
J Gen Intern Med. 2015 Dec;30(12):1780-7. doi: 10.1007/s11606-015-3381-8. Epub 2015 May 19.
9
The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging study.肝硬化的病因是脑储备的一个重要决定因素:一项多模态磁共振成像研究。
Liver Transpl. 2015 Sep;21(9):1123-32. doi: 10.1002/lt.24163. Epub 2015 Jul 21.
10
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.